I need some sales if I'm going to stay in business.  Please place orders via the affiliate links on this web site.  It's the same price.  If you bookmark or type in the URL, I don't get credit for the sale.
QualityCounts.com
 Comprehensive Anti-aging Research		    
Home iHerb Int Antiaging Sys LEF at iHerb LEF at LEF Amazon.com Dr. Weil's Vitamin Advisor Contact
Anti-aging Newsletter Signup
 Newsletter Archive
 Newsletter via RSS Feed
 Research on Supplements
 Health Conditions
 Anti-aging Recommendations
 Insulin and Aging
 QualityCounts.com in Time
 Longevity Web Sites
 Drug Databases
 Longevity Affiliates:
 iHerb
 Int. Anti-aging Systems
 Life Extension Products
 Katz Gluten Free
 glutenfree.com
 Puritan's Pride
 Mozy Unlimited Backup
 Vitamin Shoppe
 DiabetesStore.Com
 The Karaoke Channel
 Medifast Diet
 Drugstore.com
 J & R Music
 Beauty.com
 Revival Soy Products
 Dr. Weil's Polaris productsicon
 Vital Choice Seafood
 Love Scent Pheromones
 Online Prescriptions
 GreatSkin.com
 Overseas Pharmacies
 Other Neat Links

Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.

Home > Health Conditions > Pancreatic Cancer

Pancreatic Cancer

Alternative News:

  • Bitter melon juice prevents pancreatic cancer in mouse models - Science Daily, 3/12/13 - "Three years ago researchers showed the effect of bitter melon extract on breast cancer cells only in a Petri dish. This study goes much, much farther. We used the juice -- people especially in Asian countries are already consuming it in quantity. We show that it affects the glucose metabolism pathway to restrict energy and kill pancreatic cancer cells" - See bitter melon extracts at iHerb.
  • In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells - Cancer Lett. 2012 Sep 26 - "Silibinin suppresses the growth of many cancers; however, its efficacy against pancreatic cancer has not been evaluated in established preclinical models. Here, we investigated in vitro and in vivo effects of silibinin against lower and advanced stages of human pancreatic carcinoma cells ... Overall, these findings show both in vitro as well as in vivo anticancer efficacy of silibinin against pancreatic cancer that could involve inhibition of cell proliferation, cell cycle arrest, apoptosis induction and/or decrease in tumor angiogenesis" - See silymarin products at iHerb.
  • L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial - Nutr J. 2012 Jul 23;11(1):52 - "Cachexia, a >10% loss of body-weight, is one factor determining the poor prognosis of pancreatic cancer. Deficiency of L-Carnitine has been proposed to cause cancer cachexia ... While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive oral supplementation of L-Carnitine" - See L-carnitine products at iHerb.
  • High dietary antioxidant intake might cut pancreatic cancer risk - Science Daily, 7/23/12 - "Increasing dietary intake of the antioxidant vitamins C, E, and selenium could help cut the risk of developing pancreatic cancer by up to two thirds ... weekly intake of selenium in the top 25% of consumption roughly halved their risk of developing pancreatic cancer compared with those whose intake was in the bottom 25% ... those whose vitamins C, E, and selenium intake was in the top 25% of consumption were 67% less likely to develop pancreatic cancer than those who were in the bottom 25%"
  • Fiber may boost pancreatic health: Study - Nutra USA, 1/25/12 - "The greatest intakes of soluble fiber were linked to a 60% reduction in pancreatic cancer risk, while insoluble fiber intake was linked to a 50% reduction in risk" - [Abstract] - See Jarrow Formulas, Fiber Perfect, 150 Veggie Caps at iHerb.
  • COFFEE, TEA AND SUGAR-SWEETENED CARBONATED SOFT DRINK INTAKE AND PANCREATIC CANCER RISK: A POOLED ANALYSIS OF 14 COHORT STUDIES - Cancer Epidemiol Biomarkers Prev. 2011 Dec 22 - "Sugar-sweetened carbonated soft drink (abbreviated as SSB) intake has been associated with higher circulating levels of insulin, which may promote carcinogenesis. Few prospective studies have examined SSB intake and pancreatic cancer risk; results have been heterogeneous ... pooled analysis from 14 prospective cohort studies ... No statistically significant associations were observed between pancreatic cancer risk and intake of coffee (MVRR=1.10, 95% CI=0.81-1.48 comparing >900 to <0g/day; 237g≈8oz), tea (MVRR=0.96, 95% CI=0.78-1.16 comparing >400 to 0g/day; 237g≈8oz) or SSB (MVRR=1.19, 95% CI=0.98-1.46 comparing >250 to 0g/day; 355g≈12oz) (p-value, test for between-studies heterogeneity >0.05). These associations were consistent across levels of sex, smoking status and body mass index. When modeled as a continuous variable, a positive association was evident for SSB (MVRR=1.06, 95% CI=1.02-1.12)"
  • Vitamin D may slash pancreatic cancer risk: Harvard study - Nutra USA, 12/14/11 - "Data from over 1,500 people collected over 14 years indicated that people with vitamin D insufficiency were at a 30% increased risk of developing pancreatic cancer, compared with people with adequate levels of the sunshine vitamin ... Pancreatic cancer is the fourth leading causing of cancer death (about 37,500 per year) in the US" - [Abstract] - See vitamin D products at iHerb.
  • Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer - Cancer Epidemiol Biomarkers Prev. 2011 Nov 15 - "Mean plasma 25(OH)D was lower in cases versus controls (61.3 vs. 64.5 nmol/L, P=0.005). In logistic regression models, plasma 25(OH)D was inversely associated with odds of pancreatic cancer. Participants in quintiles two through five had multivariable-adjusted odds ratios (OR [95% confidence intervals]) of 0.79 (0.56-1.10), 0.75 (0.53-1.06), 0.68 (0.48-0.97), and 0.67 (0.46-0.97); P-trend=0.03), respectively, compared to the bottom quintile. Compared to those with insufficient levels (25[OH]D<50 nmol/L), ORs were 0.75 (0.58-0.98) for subjects with relative insufficiency (25[OH]D 50-<75 nmol/L) and 0.71 (0.52-0.97) for those with sufficient levels (25[OH]D≥75 nmol/L). No increased risk was noted in subjects with 25(OH)D ≥100 nmol/L, as suggested in a prior study. In subgroup analyses, ORs for the top versus bottom quartile of 25(OH)D were 0.72 (0.48-1.08) for women, 0.73 (0.40-1.31) for men, and 0.73 (0.51-1.03) for Whites ... Low circulating 25(OH)D may predispose individuals to the development of pancreatic cancer" - See vitamin D products at iHerb.
  • Physical activity, energy restriction, and the risk of pancreatic cancer: a prospective study in the Netherlands - Am J Clin Nutr. 2011 Sep 28 - "For past sports activities, we observed a significantly decreased risk of pancreatic cancer (HR: 0.80; 95% CI: 0.64, 0.99). Proxies for energy restriction were not related to pancreatic cancer risk. When the results for energy restriction were stratified by height, a significant multiplicative interaction was observed for the Economic Depression period (P = 0.002). Shorter individuals (height less than the sex-specific median adult height) with an unemployed father during the Economic Depression period had a significantly lower cancer risk (HR: 0.31; 95% CI: 0.14, 0.66) than did taller individuals with an employed father. No significant interactions were observed for exposure to energy restriction during the World War II years and the Hunger winter"
  • Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets - Int J Cancer. 2011 Sep 20. doi: 10.1002/ijc.26442 - "Zyflamend inhibited the proliferation of pancreatic cancer cell lines regardless of p53 status and also enhanced gemcitabine-induced apoptosis. This finding correlated with inhibition of NF-kB activation by Zyflamend and suppression of cyclin D1, c-myc, COX-2, Bcl-2, IAP, survivin, VEGF, ICAM-1, and CXCR4. In nude mice, oral administration of Zyflamend alone significantly inhibited the growth of orthotopically transplanted human pancreatic tumors, and when combined with gemcitabine, further enhanced the antitumor effects. Immunohistochemical and Western blot analyses of tumor tissue showed that the suppression of pancreatic cancer growth correlated with inhibition of proliferation index marker (Ki-67), COX-2, MMP-9, NF-kB, and VEGF. Overall, these results suggest that the concentrated multiherb product Zyflamend alone can inhibit the growth of human pancreatic tumors and, in addition, can sensitize pancreatic cancers to gemcitabine through the suppression of multiple targets linked to tumorigenesis" - See Zyflamend products at iHerb.
  • Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression - Int J Cancer. 2011 Feb 3 - "Ninety percent of cancer-mediated deaths are due to metastasis of the tumor; however, the mechanisms controlling metastasis remain poorly understood. Thus, no therapy targeting this process has yet been approved. Chemokines and their receptors are mediators of chronic inflammation and have been linked to the metastasis of numerous cancers. More recently, the Cysteine X Cysteine (CXC) chemokine receptor 4 (CXCR4) has emerged as a key mediator of tumor metastasis; therefore, identification of inhibitors of this receptor has the potential to abrogate metastasis. In this report, we demonstrate that acetyl-11-keto-β-boswellic acid (AKBA), a component of the therapeutic plant Boswellia serrata, can downregulate CXCR4 expression in pancreatic cancer cells. The reduction in CXCR4 induced by this terpenoid was found to be cell-type specific, as its expression was also abrogated in leukemia, myeloma and breast cancer cell lines. Neither proteasome inhibitors nor lysosomal stabilization could prevent the AKBA-induced reduction in CXCR4 expression. This downregulation occurred at the transcriptional level. Suppression of CXCR4 by AKBA was accompanied by the inhibition of pancreatic cancer cell invasion, which is induced by CXCL12, the ligand for CXCR4. In addition, abrogation of the expression of chemokine receptor by AKBA was found in human pancreatic tissues from orthotopic animal model. AKBA also abolished breast tumor cell invasion, and this effect correlated with the disappearance of both the CXCR4 messenger RNA and CXCR4 protein. Overall, our results show that AKBA is a novel inhibitor of CXCR4 expression and, thus, has the potential to suppress the invasion and metastasis of cancer cells" - See boswellia products at iHerb
  • Omega-3, vitamins C and E may boost pancreatic health - Nutra USA, 9/9/10 - "consuming at least 850 milligrams of omega-3 fatty acids per day was associated with a 53 percent reduction in the risk of pancreatic cancer, compared to intakes of between 330 and 580 milligrams per day ... According to findings published in the International Journal of Cancer, benefits were also observed for intakes of vitamin C and E, the highest average intakes associated with 31 and 33 percent reductions, respectively, compared with the lowest average intakes" - [Abstract] - See Jarrow FamilE (contains all eight members of the vitamin E family, includes Tocomin) at iHerb and Mega Twin EPA at iHerb and Jarrow Max DHA at iHerb.
  • Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area - Int J Cancer. 2010 Oct 15;127(8):1893-904 - "Positive associations were observed for high levels of the 8 individual saturated fatty acids (4th vs. 1st quartile: ORs ranged from 1.6 to 2.6; all p(trend) < 0.01), monounsaturated palmitoleic and oleic fatty acids [OR = 1.6 (95% CI: 1.2-2.1) and 1.4 (95% CI: 1.1-1.9); both p(trend) < 0.01], and polyunsaturated linolenic acid [OR = 1.5 (95% CI: 1.1-2.0); p(trend) = 0.02]. Inverse associations were observed for high levels of gadolic acid [4th vs. 1st quartile: OR = 0.68 (95% CI: 0.50-0.92); p(trend) = 0.007] and omega-3 fatty acids [>or=0.85 g/day vs. 1st quartile: OR = 0.47 (95% CI: 0.25-0.90)]. An inverse association was also observed for high total intake of vitamin C [4th vs. 1st quartile: OR = 0.69 (95% CI: 0.51-0.94); p(trend) = 0.004] and of vitamin E [OR = 0.67 (95% CI: 0.49-0.92); p(trend) = 0.01]" - See Jarrow FamilE (contains all eight members of the vitamin E family, includes Tocomin) at iHerb and Mega Twin EPA at iHerb and Jarrow Max DHA at iHerb.
  • Pancreatic cancers use fructose, common in the Western diet, to fuel their growth - Science Daily, 8/2/10 - "The bottom line is the modern diet contains a lot of refined sugar including fructose and it's a hidden danger implicated in a lot of modern diseases, such as obesity, diabetes and fatty liver ... the pancreatic cancer cells could easily distinguish between glucose and fructose even though they are very similar structurally, and contrary to conventional wisdom, the cancer cells metabolized the sugars in very different ways. In the case of fructose, the pancreatic cancer cells used the sugar in the transketolase-driven non-oxidative pentose phosphate pathway to generate nucleic acids, the building blocks of RNA and DNA, which the cancer cells need to divide and proliferate"
  • New combination effective against pancreatic cancer: Substance in broccoli supports cancer therapy, study finds - Science Daily, 6/15/10 - "Sorafenib is used for advanced liver and kidney cancer and also appears to be effective against cancer stem cells in pancreatic cancer ... It inhibits resistant tumor stem cells and is also especially effective in combination with sulforaphane, an organic compound found in broccoli ... vegetables from the cruciferous family such as broccoli and cauliflower possess a high content of sulforaphane, an anti-cancer compound. The experiments show that sulforaphane prevents the activation of the NF-kB pathway by sorafenib. The combination treatment reinforces the effect of sorafenib without causing additional side effects" - See sulforaphane products at iHerb.
  • Soft drink consumption may markedly increase risk of pancreatic cancer - Science Daily, 2/8/10 - "Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold compared to individuals who did not consume soft drinks" - [Abstract]
  • Curcumin active in pancreatic cancer patients - Nutra USA, 8/22/08
  • Herbal Extract Inhibits Development Of Pancreatic Cancer - Science Daily, 4/19/09
  • Mounting Evidence Shows Red Wine Antioxidant Kills Cancer - Science Daily, 3/25/08 - "Rochester researchers showed for the first time that a natural antioxidant found in grape skins and red wine can help destroy pancreatic cancer cells by reaching to the cell's core energy source, or mitochondria, and crippling its function ... The new study also showed that when the pancreatic cancer cells were doubly assaulted -- pre-treated with the antioxidant, resveratrol, and irradiated -- the combination induced a type of cell death called apoptosis, an important goal of cancer therapy" - [WebMD] - See Jarrow Resveratrol 100 at iHerb.
  • A Fiber-rich Diet May Cut Pancreatic Cancer Risk - oncologystat.com, 11/23/07 - "A diet high in whole grains and fiber may reduce the risk of developing pancreatic cancer by as much as 40%"
  • Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study - Am J Clin Nutr. 2007 Nov;86(5):1495-501 - "Glycemic load and added sugars were not significantly associated with pancreatic cancer risk. The risk increased with higher intakes of total sugars, fructose, and sucrose, and the association with fructose was significant when the highest and lowest quartiles were compared (relative risk: 1.35; 95% CI: 1.02, 1.80; P for trend = 0.046). A significant association was found with fruit and juices intake (1.37; 1.02, 1.84; P for trend = 0.04) but not with soda intake. Statistical evidence of a significant interaction with body mass index was present only for sucrose intake (P = 0.04). A comparison of the highest and lowest quartiles of sucrose intake in overweight or obese participants gave a relative risk of 1.46 (0.95-2.25; P for trend = 0.04), but the comparison was not significant in normal-weight participants"
  • Apples and onions may slash pancreatic cancer risk - Nutra USA, 10/1/07 - "Of the three individual flavonols, they report that kaempferol was associated with the largest risk reduction (22 per cent) across all participants"
  • Mistletoe in Supportive Care for Colorectal and Pancreatic Cancers - Doctor's Guide, 7/12/07 - "Use of a fermented mistletoe extract (MEx; Iscador®) in long-term supportive care in hospitals and private practices demonstrated significant survival benefit and improvements in quality of life for patients with surgically treated primary, nonmetastatic colorectal carcinoma and for patients with all-stages pancreatic carcinoma, when combined with adjuvant chemotherapy and/or radiotherapy or passive aftercare in two multicentre, controlled, retrospective, epidemiological, observational, cohort studies"
  • Popular Herbal Supplement Hinders The Growth Of Pancreatic Cancer Cells - Science Daily, 4/17/07 - "an extract of triphala, the dried and powdered fruits of three plants, caused pancreatic cancer cells to die through a process called apoptosis -- the body's normal method of disposing of damaged, unwanted or unneeded cells. This process often is faulty in cancer cells" - See triphala products at iHerb.
  • Flavonol-rich diet may slash pancreatic cancer risk - Nutra USA, 4/16/07
  • Vitamin D May Cut Pancreatic Cancer Risk By Nearly Half - Science Daily, 9/12/06 - "taking the U.S. Recommended Daily Allowance of Vitamin D (400 IU/day) reduced the risk of pancreatic cancer by 43 percent ... Vitamin D has shown strong potential for preventing and treating prostate cancer, and areas with greater sunlight exposure have lower incidence and mortality for prostate, breast, and colon cancers"
  • High-vegetable Diet Linked To Protection Against Pancreatic Cancer - Science Daily, 9/19/05 - "fruits and vegetables -- particularly vegetables -- is associated with about a 50 percent reduction in the risk of developing pancreatic cancer"
  • More Vegetables Lowers Chance of Deadly Cancer - WebMD, 9/16/05
  • Dietary Intake of Lycopene Is Associated with Reduced Pancreatic Cancer Risk - J Nutr. 2005 Mar;135(3):592-597 - "After adjustment for age, province, BMI, smoking, educational attainment, dietary folate, and total energy intake, lycopene, provided mainly by tomatoes, was associated with a 31% reduction in pancreatic cancer risk among men"
  • Regular aspirin use linked to pancreatic cancer - USA Today, 10/28/03 - "women who reported 20 or more years of regular aspirin use, with an average intake of at least two or more tablets a week, had a 58% increased risk of pancreatic cancer, compared to those who did not take aspirin. Among those who took 14 tablets or more a week, the risk was 86% greater"
  • What vitamins or herbs do you suggest taking for cancer of the pancreas? - Dr. Weil, 6/5/03
  • Aspirin May Ward Off Pancreas Cancer - Intelihealth, 8/8/02
  • Aspirin Lowers Pancreatic Cancer Risk - WebMD, 8/6/02 - "A new study shows regular use of aspirin might lower your risk of one of the deadliest forms of cancer ... women who used aspirin cut their risk of developing pancreatic cancer nearly in half ... the more aspirin use a woman reported, the less likely she was to develop pancreatic cancer ... Other NSAIDs did not have the same effect"
  • Report: An Innovative Approach to Cancer Therapy - Life Extension Magazine, 8/01
  • B Vitamins Cut Cancer Risks - Nutrition Science News, 7/01
  • Unusual dietary treatment may fight pancreatic cancer - CNN, 11/29/99
  • A Promising Cancer Therapy - Life Extension Magazine, 7/99

Other News: